Abstract submission is now closed
The organizers are pleased to announce a call for abstracts for oral and poster presentation.
All submitted abstracts will be reviewed for acceptance based on their scientific merit.
Kindly specify if you would prefer an oral or poster presentation on the online submission form. The authors will be informed in due time whether their abstracts have been accepted, and whether for oral or poster presentation.
Inclusion of abstracts in the scientific program is dependent on payment of registration fees.
The Organizers welcome abstract submissions for poster and oral presentations on the topics that are listed, but not limited to, those mentioned:
- Current and future ocular drug therapy:
- Drug Delivery
- Drug Development
- Innovation in Ophthalmology
Abstracts must be submitted using the on-line submission link. Please do not fax, mail or email your abstracts as they will not be considered.
All abstracts must be submitted in English.
The names and affiliations of all authors should be included in the abstract.
Abstracts should be no longer than 280 words (excluding title and affiliations).
Once you have submitted your abstract you can edit the document/authors/affiliations etc. by logging in again.
Please note that this feature is only available up until the submission deadline of or until the abstract has been accepted.
You can check the status of abstracts submitted by logging in. Click on the abstract tab to track the review process.
Once your abstract has been reviewed you will also receive an email notification.
Keep note of your username and password so you can use these features.